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A PCR assay with primers derived from the 16S rRNA sequence of Brucella abortus was developed. Nine
different combinations between six primers were tested. One pair of primers, which amplified a 905-bp
fragment, was selected. As little as 80 fg of Brucella DNA was detected by this method. DNAs from all of the
representative strains of the species and biovars of Brucella and from 23 different Brucella isolates were
analyzed and yielded exclusively the 905-bp fragment. No amplification was detected with DNAs from 10
strains phylogenetically related to Brucella spp., 5 gram-negative bacteria showing serological cross-reactions
with Brucella spp., and 36 different clinical isolates of non-Brucella species. Only Ochrobactrum anthropi biotype
D yielded a PCR product of 905 bp, suggesting a closer relationship between Brucella spp. and O. anthropi
biotype D. The specificity and high sensitivity of the PCR assay may provide a valuable tool for the diagnosis
of brucellosis.
The members of the genus Brucella are gram-negative aer-
obic bacteria which multiply within macrophages and cause
infections in animals and humans. Six nomen species (B. abor-
tus, B. melitensis, B. suis, B. ovis, B. canis, and B. neotomae) are
recognized; it has been proposed that B. melitensis be the
genomic species (15). On the basis of 16S rRNA sequence
comparisons, the genus Brucella has been found to be a mem-
ber of the alpha-2 subdivision of the class Proteobacteria,
closely related to Rochalimaea, Rhizobium, and Agrobacterium
spp. (11, 12).
Brucellosis causes great economic losses and human suffer-
ing. Currently, the diagnosis of this zoonosis is based on mi-
crobiological and serological laboratory tests. Although the
most specific diagnostic test is isolation of the causative organ-
ism, long incubation periods are necessary, and cultures are
not always positive when other tests are positive. Thus, the use
of serological methods is recommended as a means to obtain
indirect proof of the diagnosis. However, the presence of an-
tibodies does not always mean an active case of brucellosis:
humans from areas where brucellosis is endemic often show
weak serological responses, and vaccinated animals may yield
false-positive results, and other gram-negative bacteria may
cross-react with smooth Brucella spp. (3, 5).
Amplification of DNA by PCR is currently used for the
diagnoses of several infectious diseases caused by fastidious or
slowly growing bacteria. Although previous studies have dem-
onstrated that PCR can be used to detect Brucella DNA (1,
7–9), a more extensive evaluation with a wide range of bacteria
is necessary. This report describes a highly sensitive PCR
method for the detection of Brucella spp., using a genus-spe-
cific primer pair derived from the 16S rRNA sequence of B.
abortus. By testing all of the biovars and species of Brucella and
a series of clinical and field isolates of Brucella, we have dem-
onstrated the high specificity of this PCR assay. We also stud-
ied a large number of other genera, including bacteria phylo-
genetically or serologically related to Brucella spp. and
including other microorganisms that, like Brucella spp., can
produce bacteremia in humans or are intracellular pathogens.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The strains used in this study are
listed in Table 1. These strains include the reference strains of all of the species
and biotypes of Brucella, strains from four genera belonging to the alpha-2
subdivision of the class Proteobacteria, and five gram-negative bacteria that are
known to cross-react serologically with Brucella spp. (3). In addition, a total of 59
clinical and field isolates were included. Clinical samples were obtained from
different hospitalized patients in a university clinic, and field isolates were col-
lected from infected animals (Table 2). Isolates were identified by standard
methods. Brucella strains were grown on tryptic soy agar at 378C for 48 h.
Agrobacterium, Phyllobacterium, Alcaligenes, and Ochrobactrum strains were
grown on the same medium at 268C. Other bacteria were grown on nutrient agar
at 378C for 24 h, with the exception of those with specific growth requirements.
TheMycobacterium sp. was grown on Lo¨wenstein-Jensen medium and incubated
at 378C until growth became clearly visible. Clostridium and Propionibacterium
spp. needed an anaerobic atmosphere, and Neisseria meningitidis and Haemophi-
lus influenzae were cultured on chocolate agar with 10% CO2.
Extraction of genomic DNA from bacterial cultures. A modification of the
method described by Wilson (16) was used. Briefly, cells were resuspended in 0.5
ml of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0), heat killed at 808C for
15 min, and incubated at 378C for 1 h with 0.5% sodium dodecyl sulfate and
proteinase K (200 mg/ml). Cell wall debris, denatured proteins, and polysaccha-
rides were removed by precipitation with 5 M NaCl and CTAB-NaCl solution
and incubated at 658C for 10 min. DNA was extracted by a standard protocol
with phenol-chloroform-isoamyl alcohol, precipitated with isopropanol, washed
with 70% ethanol, and dried (13). The pellet of DNA was redissolved in 50 to 100
ml of distilled sterile water. The concentration and purity of the DNA were
determined spectrophotometrically by readings of A260, A280, and A310. Samples
were diluted up to 0.08 mg/ml and stored at 2208C. Negative controls with
distilled water instead of cells were treated exactly as the samples were.
Primer design. The 16S rRNA sequences of B. abortus (EMBL accession
number X13695), Rochalimaea quintana (M11927 and M73228), Rochalimaea
vinsonii (L01259 and M73230), Rochalimaea saintelizabethsina (L01260), Brady-
rhizobium japonicum (S46916), Agrobacterium tumefaciens (M11223), Rhodo-
pseudomonas globiformis (M59066), and Rhodopseudomonas palustris (M59068)
were aligned and compared, allowing the design of six oligonucleotides poten-
tially specific for Brucella spp. (Table 3). The oligonucleotides were synthesized
on a model 391 DNA synthesizer (Applied Biosystems, Inc.). Nine different
combinations between the forward (F1, F3, and F4) and the reverse (R1, R2,
and R3) primers were tested. The expected sizes of the amplification products
were as follows: F1-R1, 803 bp; F1-R2, 820 bp; F1-R3, 833 bp; F3-R1, 844 bp;
F3-R2, 861 bp; F3-R3, 874 bp; F4-R1, 888 bp; F4-R2, 905 bp; and F4-R3, 918
bp.
DNA amplification by PCR. Amplification reaction mixtures for the pair
F4-R2 were prepared in a volume of 25 ml containing 50 mM KCl–10 mM
Tris-HCl (pH 9.0)–0.10% Triton X-100 (13 reaction buffer; Promega Biotec),
200 mM each deoxynucleoside triphosphate, 0.5 mM each primer, 0.5 U of Taq
DNA polymerase (Promega Biotec), and 1 ml of template DNA (80 ng). The
magnesium concentration was optimized at 1 mM MgCl2 (see Results). The
mixture was overlaid with 50 ml of mineral oil (Sigma Chemical Co.), and the
amplification was performed in a Gene ATAQ Controller System (Pharmacia
Biotech, S.A.). Negative controls containing all of the reagents but lacking
template DNA were routinely processed exactly as described above to monitor
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contamination with Brucella DNA. After an initial denaturation at 958C for 5
min, the PCR profile was set as follows: 30 s of template denaturation at 958C,
90 s of primer annealing at 548C, and 90 s of primer extension at 728C, for a total
of 30 cycles, with a final extension at 728C for 6 min. The samples were analyzed
by electrophoresis (70 V for 2 h) in a 0.8% agarose D1 (Hispanlab, S.A.) gel in
TBE buffer (89 mM Tris-HCl, 89 mM boric acid, 2.0 mM EDTA, pH 8.0). PCR
amplification products were detected by visualization of the bands under UV
light after the gel was soaked with 2 mg of ethidium bromide per ml. Each sample
was tested twice in different independent experiments.
Nucleotide sequence determination. DNA sequences were obtained by the
dideoxy-chain termination method of Sanger et al. (14). DNAs to be used as
sequencing templates were PCR products purified with the Wizard PCR Preps
DNA Purification System (Promega Biotec). The templates were resuspended in
a sequencing buffer supplied in the Sequenase 2.0 DNA sequencing kit (United
States Biochemical Corp.). Sequencing reactions were performed according to
the manufacturer’s instructions, and products were electrophoresed on 6% poly-
acrylamide gels and exposed to XAR-2 X-ray film at room temperature.
RESULTS AND DISCUSSION
To select the optimum pair of primers which would specif-
ically amplify Brucella DNA, nine different combinations be-
tween the forward and reverse primers were tested. Both B.
abortus 2308 DNA and Escherichia coli O:111 DNA (negative
control) were used as templates in these initial optimization
studies. Since amplification conditions for the different combi-
nations of the oligonucleotides could be different, the influence
of the following PCR parameters was assayed: annealing tem-
perature from 50 to 588C, Mg21 concentration from 0.5 to 2.5
mM, Taq polymerase concentration from 0.25 to 0.75 U per
reaction, and number of cycles of amplification. The strongest,
most specific, and most reproducible amplification was
achieved with the F4-R2 pair under the conditions described in
Materials and Methods (Fig. 1). Therefore, all subsequent
TABLE 1. PCR results with DNAs from Brucella strains and from
bacteria phylogenetically or serologically related to Brucella spp.
Bacterium Strain Origina PCR
Brucella abortus biovar 1 2308 NADC 1
Brucella abortus biovar 1 RB51 G. Schuring 1
Brucella abortus biovar 2 86/8/59 INRA 1
Brucella abortus biovar 3 Tulya INRA 1
Brucella abortus biovar 4 292 INRA 1
Brucella abortus biovar 5 B3196 INRA 1
Brucella abortus biovar 6 870 INRA 1
Brucella abortus biovar 9 87/46 INRA 1
Brucella melitensis biovar 1 16M CVL 1
Brucella melitensis biovar 2 63/9 INRA 1
Brucella melitensis biovar 3 Ether INRA 1
Brucella suis biovar 1 1330 INRA 1
Brucella suis biovar 2 Thomsen INRA 1
Brucella suis biovar 3 686 INRA 1
Brucella suis biovar 4 40 INRA 1
Brucella suis biovar 5 513 INRA 1
Brucella ovis Bow-CO2
2 INRA 1
Brucella neotomae 56239 INRA 1
Brucella canis INRA 1
Agrobacterium tumefaciensb 10854 ICPB 2
Agrobacterium rhizogenesb 020-AP IVIA 2
Agrobacterium vitisb 565-5 IVIA 2
Phyllobacterium sp.b 8225 LMG 2
Phyllobacterium myrsinacearumb 2t2 LMG 2
Phyllobacterium rubiacearumb 1t1 LMG 2
Ochrobactrum anthropi biotype Ab,c 3331 LMG 2
Ochrobactrum anthropi biotype Db,d 3301 LMG 1
Alcaligenes denitrificansb 15173 ATCC 2
Alcaligenes denitrificansb 27061 ATCC 2
Xanthomonas maltophiliae 113 CECT 2
Yersinia enterocolitica O:9e E518/90 G. Waters 2
Vibrio cholerae O:1e CUN 2
Salmonella urbanae CUN 2
Escherichia coli O:157e CUN 2
Escherichia coli O:111f NIBSC 2
a NADC, National Animal Disease Center, Ames, Iowa; INRA, Institut Na-
tionale de la Recherche Agronomique, Tour, France; CVL, Central Veterinary
Laboratory, Weybridge, England; ICPB, International Collection of Phytopatho-
genic Bacteria, University of California, Davis; IVIA, Instituto Valenciano de
Investigaciones Agrarias, Valencia, Spain; LMG, Culture Collection of the Lab-
oratory for Microbiology, Ghent, Belgium; ATCC, American Type Culture Col-
lection, Rockville, Md.; CECT, Coleccio´n Espan˜ola de Cultivos Tipo, Valencia,
Spain; CUN, Clı´nica Universitaria, Universidad de Navarra, Pamplona, Spain;
NIBSC, National Institute for Biological Standards and Control, London, En-
gland.
b Phylogenetically related to Brucella spp.
c Type strain (10).
d Originally isolated from human blood (10).
e Serologically related to Brucella spp.
f Negative control.
TABLE 2. PCR results with DNAs from clinical and field isolates
Species (no. of isolates) Source PCR
Achromobacter sp. (1) Human 2
Acinetobacter calcoaceticus (1) Human 2
Brucella melitensis (13) Human 1
Brucella melitensis (5) Bovine 1
Brucella ovis (5) Ram 1
Campylobacter sp. (1) Human 2
Candida albicans (1) Human 2
Citrobacter freundii (1) Human 2
Clostridium sp. (1) Meat 2
Enterococcus faecalis (2) Human 2
Escherichia coli (2) Human 2
Haemophilus influenzae (2) Human 2
Klebsiella pneumoniae (2) Human 2
Listeria monocytogenes (1) Meat 2
Mycobacterium tuberculosis (2) Human 2
Neisseria meningitidis (1) Human 2
Ochrobactrum anthropi (1) Human 2
Propionibacterium sp. (1) Human 2
Proteus mirabilis (1) Human 2
Pseudomonas aeruginosa (1) Human 2
Pseudomonas maltophilia (1) Human 2
Salmonella enteritidis (1) Human 2
Salmonella typhi (1) Human 2
Salmonella typhimurium (2) Human 2
Serratia marcescens (1) Human 2
Shigella sp. (1) Human 2
Staphylococcus aureus (2) Human 2
Staphylococcus epidermidis (1) Human 2
Streptococcus faecalis (1) Human 2
Streptococcus pneumoniae (1) Human 2
Streptococcus viridans (1) Human 2
Xanthomonas sp. (1) Human 2
TABLE 3. Sequences and locations of primers used for
PCR amplification
Primer Sequence Locationa
F1 59-TGC TAA TAC CGT ATG TGC TT-39 148–167
F3 59-GGG AAC GTA CCA TTT GCT A-39 107–125
F4 59-TCG AGC GCC CGC AAG GGG-39 63–79
R1 59-TAA CCG CGA CCG GGA TGT-39 932–949
R2 59-AAC CAT AGT GTC TCC ACT AA-39 947–966
R3 59-TCC AGC CTA ACT GAA CCA TA-39 960–979
a Based on the nucleotide sequence of the B. abortus 16S rRNA described by
Dorsch et al. (6).
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experiments were performed with these primers and under
these conditions.
To confirm the identity of the PCR product, the nucleotide
sequence of each end of the fragment was determined and
compared with the Brucella 16S rRNA sequence described by
Dorsch et al. (6). The results confirmed the amplification of
the correct fragment (data not shown).
We also tested the ability of the PCR assay to amplify DNAs
from other strains of Brucella. Under the optimal conditions
described in Materials and Methods, all of the representative
strains of the different species and biovars of Brucella and 23
Brucella isolates yielded only the predicted 905-bp fragment of
amplified DNA (Tables 1 and 2). This result is in agreement
with that of De Ley et al. (4), who found that the genus
Brucella forms a very tight genetic cluster, and with the pro-
posal of a single genomic species for Brucella (15).
To determine the specificity of the primers selected, DNAs
from 10 different strains phylogenetically related to Brucella
spp. and from 5 gram-negative bacteria showing serological
cross-reactions with Brucella spp. (Table 1) were assayed. No
amplification products were observed, with the sole exception
of Ochrobactrum anthropi LMG 3301 DNA, which yielded a
PCR product of 905 bp. The genus Ochrobactrum (formerly in
CDC group Vd) is also a member of the alpha-2 subdivision of
the class Proteobacteria and is the closest known neighbor of
the genus Brucella (10). However, it is unlikely that O. anthropi
would cause a false-positive result in a test for Brucella spp.
with the PCR assay described here, since O. anthropi has rarely
been found to be pathogenic (2, 10). In addition, it is signifi-
cant that DNAs from O. anthropi LMG 3331 (type strain) and
from a clinical isolate of O. anthropi (from blood of an immu-
nocompromised patient) were not amplified (Tables 1 and 2).
The clinical isolate was characterized by the National Collec-
tion of Type Cultures (Public Health Laboratory Service, Lon-
don, England) as belonging to biotype A. The genus Ochrobac-
trum is a broad group, and it has been reported that the relative
binding ratios of O. anthropi LMG 3331 (biotype A) DNA with
O. anthropi LMG 3301 (biotype D) DNA and Brucella DNA
are 41 and 20 to 30%, respectively (10). In this regard, our
results confirm the genetic heterogeneocity of the genus
Ochrobactrum and suggest a closer relationship between Bru-
cella spp. and O. anthropi biotype D (4). The PCR specificity
was also evaluated by using a total of 36 isolates of other
genera different from Brucella (Table 2), including intracellular
pathogens and microorganisms able to cause bacteremia. All
samples tested were also negative, confirming the high speci-
ficity of the PCR assay proposed.
Finally, the threshold sensitivity of the PCR assay was de-
termined by testing serial dilutions of B. abortus 2308 DNA
from 80 ng to 0.08 fg. As little as 80 fg of DNA was detected
after 40 cycles of amplification (Fig. 1). Similar findings with
respect to the amount of Brucella DNA detected by PCR have
been obtained by using primers based on the genes encoding a
43-kDa outer membrane protein (8) and a 31-kDa B. abortus
antigen (1). In those reports, the authors suggested that 60 to
100 fg of bacterial DNA is equivalent to 20 cells.
In conclusion, on the basis of its sensitivity and specificity,
this PCR method based on the sequence of the 16S rRNA of
B. abortus could provide a useful diagnostic tool for brucellosis.
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FIG. 1. Sensitivity of PCR assay for detection of B. abortus 2308 DNA. Lanes
2 to 9, different amounts of template DNA, as follows: 800 pg (lane 2), 80 pg
(lane 3), 8 pg (lane 4), 800 fg (lane 5), 80 fg (lane 6), 8 fg (lane 7), 0.8 fg (lane
8), and no template DNA (lane 9). Lane 1, fX174 DNA/HaeIII marker (Boehr-
inger-Mannheim, S.A.). The 905-bp PCR product is indicated.
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